PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: Evolocumab

Chanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, Aditya Hendrani, Matthew J. Feinstein, Arman Qamar, Parag H. Joshi, Kristopher J. Swiger, Kathleen Byrne, Renato Quispe, Steven R. Jones, Roger S. Blumenthal, Seth S. Martin

Research output: Contribution to journalReview article

5 Scopus citations

Fingerprint Dive into the research topics of 'PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: Evolocumab'. Together they form a unique fingerprint.

Medicine & Life Sciences